Developing plant-based vaccines against neglected tropical diseases: Where are we?

Vaccine

Volumn 31, Issue 1, 2012, Pages 40-48

  Rosales Mendoza, Sergio ^a   Govea Alonso, Dania O ^a   Monreal Escalante, Elizabeth ^a   Fragoso, Gladis ^b   Sciutto, Edda ^b  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Developing countries; Low cost vaccination; Oral immunization; Transgenic plant; Vaccines

Indexed keywords

CHOLERA TOXIN B SUBUNIT; DENGUE VACCINE; EG 95; PAPAYA VACCINE; RABIES VACCINE; UNCLASSIFIED DRUG; VACCINE;

CYSTICERCOSIS; DENGUE; ECHINOCOCCUS GRANULOSUS; HEALTH CARE COST; HELMINTHIASIS; IMMUNE RESPONSE; MASS IMMUNIZATION; NEUROCYSTICERCOSIS; NONHUMAN; PRIORITY JOURNAL; RABIES; REVIEW; TAENIA SOLIUM; TROPICAL DISEASE;

DEVELOPING COUNTRIES; HUMANS; NEGLECTED DISEASES; PLANTS, GENETICALLY MODIFIED; TROPICAL MEDICINE; VACCINES;

EID: 84870558079     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.094     Document Type: Review

References (67)

1. WHO (World Health Organization). First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. WHO/HTM/NTD/2010.1.
2. Cripps A.W., Kyd J.M., Foxwell A.R. Vaccines and mucosal immunization. Vaccine 2001, 19:2513-2515.
3. Mason H.S., Warzecha H., Mor T., Arntzen C.J. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med 2002, 8:324-329.
4. Walmsley A.M., Arntzen C.J. Plant cell factories and mucosal vaccines. Curr Opin Biotechnol 2003, 14:145-150.
5. Daniell H. Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol J 2006, 1:1071-1079.
6. Yusibov V., Streatfield S.J., Kushnir N. Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies, and beyond. Hum Vaccin 2011, 7:313-321.
7. Sciutto E., Fragoso G., Fleury A., Laclette J.P., Sotelo J., Aluja A., et al. Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions. Microbes Infect 2000, 2:1875-1890.
8. Rodriguez-Canul R., Fraser A., Allan J.C., Dominguez-Alpizar J.L., Argaez-Rodriguez F., Craig P.S. Epidemiological study of Taenia solium taeniasis/cisticercosis in a rural village in Yucatan state, Mexico. Ann Trop Med Parasitol 1999, 93:57-67.
9. Schantz P.M., Tsang V.C. The US Centers for Disease Control and Prevention (CDC) and research and control of cysticercosis. Acta Trop 2003, 87:161-163.
10. Sciutto E., Martínez J.J., Huerta M., Avila R., Fragoso G., Villalobos N., et al. Familial clustering of Taenia solium cysticercosis in the rural pigs of Mexico: hints of genetic determinants in innate and acquired resistance to infection. Vet Parasitol 2003, 116:223-229.
11. Torgerson P.R., Macpherson C.N. The socioeconomic burden of parasitic zoonoses: global trends. Vet Parasitol 2011, 182:79-95.
12. Report of the WHO/FAO/OIE joint consultation on emerging zoonotic diseases 2004, WHO, WHO, Geneva, Switzerland.
13. Sarti E., Flisser A., Schantz P.M., Gleizer M., Loya M., Plancarte A., et al. Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. Am J Trop Med Hyg 1997, 56:127-132.
14. Sarti E., Schantz P.M., Avila G., Ambrosio J., Medina-Santillán R., Flisser A. Mass treatment against human taeniasis for the control of cisticercosis: a population-based intervention study. Trans R Soc Trop Med Hyg 2000, 94:85-89.
15. Pawlowski Z., Allan J., Sarti E. Control of Taenia solium taeniasis/cysticercosis: from research towards implementation. Int J Parasitol 2005, 35:1221-1232.
16. Huerta M., de Aluja A.S., Fragoso G., Toledo A., Villalobos N., Hernández M., et al. Synthetic peptide vaccine against Taenia solium pig cisticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine 2001, 20:262-266.
17. Morales J., Martínez J.J., Rosetti M., Fleury A., Maza V., Hernandez M., et al. Spatial distribution of Taenia solium porcine cisticercosis within a rural area of Mexico. PLoS Negl Trop Dis 2008, 2:e284.
18. Hernández M., Cabrera-Ponce J.L., Fragoso G., López-Casillas F., Guevara-García A., Rosas G., et al. A new highly effective anticysticercosis vaccine expressed in transgenic papaya. Vaccine 2007, 25:4252-4260.
19. Betancourt M., Aluja A., Sciutto E., Hernández M., Bobes R., Rosas G., et al. Effective protection induced by three different versions of the porcine S3Pvac anticysticercosis vaccine against rabbit experimental Taenia pisiformis cysticercosis. Vaccine 2012, 30:2760-2767.
20. Flisser A., Gauci C.G., Zoli A., Martinez-Ocaña J., Garza-Rodriguez A., Dominguez-Alpizar J.L., et al. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun 2004, 72:5292-5297.
21. Assana E., Kyngdon C.T., Gauci C.G. Elimination of Taenia solium transmission in a small-scale field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 2005, 40:515-519.
22. Jayashi C.M., Arroyo G., Lightowlers M.W., García H.H., Rodríguez S., Gonzalez A.E. Seroprevalence and risk factors for Taenia solium cysticercosis in rural pigs of northern Peru. PLoS Negl Trop Dis 2012, 6:e1733.
23. Gauci C.G., Jayashi C.M., Gonzales A.E., Lackenby J., Lightowlers M.W. Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens. Vaccine 2012, 30:3824-3828.
24. Moro P., Schantz P.M. Echinococcosis: a review. Int J Infect Dis 2009, 13:125-133.
25. Lightowlers M.W., Rolfe R., Gauci C.G. Taenia saginata: vaccination against cysticercosis in cattle with recombinant oncosphere antigens. Exp Parasitol 1996, 84:330-338.
26. Heath D.D., Jensen O., Lightowlers M.W. Progress in control of hydatidosis using vaccination-a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes. Acta Trop 2003, 85:133-143.
27. Lightowlers M.W., Heath D.D. Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts. Parasitologia 2003, 46:27-31.
28. Zhang W.B., McManus D.P. Vaccination of dogs against Echinococcus granulosus: a means to control hydatid disease?. Trends Parasitol 2008, 24:419-424.
29. Zhang Z.Z., Shi B.X., Zhang W., Gunuer T., Wang J.C., Tu Hong Y., et al. The prophylactic effect of the genetically engineering vaccine EG95 on hydatid disease of sheep. Chin J Zoonoses 2008, 24:252-256.
30. Zhang W.B., Zhang Z.Z., Yimit T., Shi B.X., Aili H., Tulson G., et al. A pilot study for control of hyperendemic cystic hydatid disease in China. PLoS Negl Trop Dis 2009, 3:e534.
31. Barnes T.S., Deplazes P., Gottstein B., Jenkins D.J., Mathis A., Siles-Lucas M., et al. Challenges for diagnosis and control of cystic hydatid disease. Acta Trop 2012, 123:1-7.
32. Cross M.L., Zheng T., Duckworth J.A., Cowan P.E. Could recombinant technology facilitate the realisation of a fertility-control vaccine for possums?. N Z J Zool 2011, 38:91-111.
33. Ye Y.J., Li W.G. Changes of cytokine secretion in mice by immunization with leaf protein extracted from Echinococcus granulosus Eg95-EgA31 transgenic alfalfa. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2010, 28:94-97.
34. Ye Y.J., Li W.G. The study on immune responses in BALB/c mice by immunization with the transgenic Alfalfa (Medicago sativa) containing Eg95-EgA31 fusion gene of Echinococcus granulosus. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010, 26:750-753.
35. Morales J., de Aluja A.S., Martínez J.J., Hernández M., Rosas G., Villalobos N., et al. Recombinant S3Pvac-phage anticysticercosis vaccine: simultaneous protection against cysticercosis and hydatid disease in rural pigs. Vet Parasitol 2011, 176:53-58.
36. Lustigman S., Prichard R.K., Gazzinelli A., Grant W.N., Boatin B.A., McCarthy J.S., et al. A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis 2012, 6:e1582.
37. Deworming for health and development: report of the third partners for parasite control meeting 2005, WHO (World Health Organization).
38. Maruyama H., Nawa Y., Noda S., Mimori T., Choi W.Y. An outbreak of visceral larva migrans due to Ascaris suum in Kyushu, Japan. Lancet 1996, 347:1766-1767.
39. Nakamura-Uchiyama F., Tokunaga Y., Suzuki A., Akao N., Hiromatsu K., Hitomi S., et al. A case of Ascaris suum visceral larva migrans diagnosed by using A. suum larval excretory-secretory (ES) antigen. Scand J Infect Dis 2006, 38:221-224.
40. Hill D.E., Fetterer R.H., Romanowski R.D., Urban J.F. The effect of immunization of pigs with Ascaris suum cuticle components on the development of resistance to parenteral migration during a challenge infection. Vet Immunol Immunopathol 1994, 42:161-169.
41. Tsuji N., Suzuki K., Kasuga-Aoki H., IsobeT, Arakawa T., Matsumoto Y. Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum. Infect Immun 2003, 71:5314-5323.
42. Tsuji N., Miyoshi T., Islam M.K., Isobe T., Yoshihara S., Arakawa T., et al. Recombinant Ascaris 16-kilodalton protein-induced protection against Ascaris suum larval migration after intranasal vaccination in pigs. J Infect Dis 2004, 190:1812-1820.
43. Matsumoto Y., Suzuki S., Nozoye T., Yamakawa T., Takashima Y., Arakawa T., et al. Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin B subunit. Transgenic Res 2009, 18:185-192.
44. Nozoye T., Takaiwa F., Tsuji N., Yamakawa T., Arakawa T., Hayashi Y., et al. Production of Ascaris suum As14 protein and its fusion protein with cholera toxin B subunit in rice seeds. J Vet Med Sci 2009, 71:995-1000.
45. Herbert D.R., Yang J.Q., Hogan S.P., Groschwitz K., Khodoun M., Munitz A., et al. Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J Exp Med 2009, 206:2947-2957.
46. Gutiérrez-Ortega A., Avila-Moreno F., Saucedo-Arias L.J., Sánchez-Torres C., Gómez-Lim M.A. Expression of a single-chain human interleukin-12 gene in transgenic tobacco plants and functional studies. Biotechnol Bioeng 2004, 85:734-740.
47. Magnuson N.S., Linzmaier P.M., Reeves R., An G., HayGlass K., Lee J.M. Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture. Protein Expr Purif 1998, 13:45-52.
48. Shakin-Eshleman S.H., Remaley A.T., Eshleman J.R., Wunner W.H., Spitalnik S.L. N-linked glycosylation of rabies virus glycoprotein, Individual sequons differ in their glycosylation efficiencies and influence on cell surface expression. J Biol Chem 1992, 267:10690-10698.
49. Ertl H.C. Novel vaccines to human rabies. PLoS Negl Trop Dis 2009, 3:e515.
50. McGarvey P.B., Hammond J., Dienelt M.M., Hooper D.C., Fu Z.F., Dietzschold B., et al. Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnology (NY) 1995, 13:1484-1487.
51. Yusibov V., Modelska A., Steplewski K., Agadjanyan M., Weiner D., Hooper D.C., et al. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci USA 1997, 94:5784-5788.
52. Modelska A., Dietzschold B., Sleysh N., Fu Z.F., Steplewski K., Hooper D.C., et al. Immunization against rabies with plant-derived antigen. Proc Natl Acad Sci USA 1998, 95:2481-2485.
53. Yusibov V., Hooper D.C., Spitsin S.V., Fleysh N., Kean R.B., Mikheeva T., et al. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine 2002, 20:3155-3164.
54. Ashraf S., Singh P.K., Yadav D.K., Shahnawaz M., Mishra S., Sawant S.V., et al. High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice. J Biotechnol 2005, 119:1-14.
55. Loza-Rubio E., Rojas E., Gómez L., Olivera M.T., Gómez-Lim M.A. Development of an edible rabies vaccine in maize using the Vnukovo strain. Dev Biol (Basel) 2008, 131:477-482.
56. Roy S., Tvagi A., Tiwari S., Singh A., Sawant S.V., Singh P.K., et al. Rabies glycoprotein fused with B subunit of cholera toxin expressed in tobacco plants folds into biologically active pentameric protein. Protein Expr Purif 2010, 70:184-190.
57. Konishi E., Yamaoka M., Kurane I., Mason P.W. A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice. Vaccine 2000, 18:1133-1139.
58. Report of the eighth meeting of the global collaboration for development of pesticides for public health 2012, WHO (World Health Organization), WHO Headquarters, Geneva, Switzerland.
59. Saejung W., Fujiyama K., Takasaki T., Ito M., Hori K., Malasit P., et al. Production of dengue 2 envelope domain III in plant using TMV-based vector system. Vaccine 2007, 25:6646-6654.
60. Modis Y., Ogata S., Clements D., Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 2003, 100:6986-6991.
61. Kim T.G., Kim M.Y., Yang M.S. Cholera toxin B subunit-domain III of dengue virus envelope glycoprotein E fusion protein production in transgenic plants. Protein Expr Purif 2010, 74:236-241.
62. Martínez C.A., Topal E., Giulietti A.M., Talou J.R., Mason H. Exploring different strategies to express Dengue virus envelope protein in a plant system. Biotechnol Lett 2010, 32:867-875.
63. Kanagaraj A.P., Verma D., Daniell H. Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts. Plant Mol Biol 2011, 76:323-333.
64. Arai Y., Shikanai T., Doi Y., Yoshida S., Yamaguchi I., Nakashita H. Production of polyhydroxybutyrate by polycistronic expression of bacterial genes in tobacco plastid. Plant Cell Physiol 2004, 45:1176-1184.
65. Quesada-Vargas T., Ruiz O.N., Daniell H. Characterization of heterologous multigene operons in transgenic chloroplasts: transcription, processing, and translation. Plant Physiol 2005, 138:1746-1762.
66. Dawson W.O. Gene silencing and virus resistance: a common mechanism. Trends Plant Sci 1996, 1:107-108.
67. Soria-Guerra R.E., Moreno-Fierros L., Rosales-Mendoza S. Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches. Plant Cell Rep 2011, 30:1367-1382.